Roshan Karunamuni
Roshan Karunamuni
Verified email at
Cited by
Cited by
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
TM Seibert, CC Fan, Y Wang, V Zuber, R Karunamuni, JK Parsons, ...
bmj 360, 2018
Dose-dependent cortical thinning after partial brain irradiation in high-grade glioma
R Karunamuni, H Bartsch, NS White, V Moiseenko, R Carmona, ...
International Journal of Radiation Oncology* Biology* Physics 94 (2), 297-304, 2016
Dose-dependent white matter damage after brain radiotherapy
M Connor, R Karunamuni, C McDonald, N White, N Pettersson, ...
Radiotherapy and Oncology 121 (2), 209-216, 2016
Radiation dose–dependent hippocampal atrophy detected with longitudinal volumetric magnetic resonance imaging
TM Seibert, R Karunamuni, H Bartsch, S Kaifi, AP Krishnan, Y Dalia, ...
International Journal of Radiation Oncology* Biology* Physics 97 (2), 263-269, 2017
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status
RL Delfanti, DE Piccioni, J Handwerker, N Bahrami, AP Krishnan, ...
Journal of neuro-oncology 135 (3), 601-609, 2017
Regional susceptibility to dose-dependent white matter damage after brain radiotherapy
M Connor, R Karunamuni, C McDonald, T Seibert, N White, V Moiseenko, ...
Radiotherapy and Oncology 123 (2), 209-217, 2017
Cerebral cortex regions selectively vulnerable to radiation dose-dependent atrophy
TM Seibert, R Karunamuni, S Kaifi, J Burkeen, M Connor, AP Krishnan, ...
International Journal of Radiation Oncology* Biology* Physics 97 (5), 910-918, 2017
Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planning
TM Seibert, NS White, GY Kim, V Moiseenko, CR McDonald, N Farid, ...
Practical radiation oncology 6 (6), e319-e328, 2016
Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma
CR McDonald, RL Delfanti, AP Krishnan, KM Leyden, ...
Neuro-oncology 18 (11), 1579-1590, 2016
Development of silica-encapsulated silver nanoparticles as contrast agents intended for dual-energy mammography
R Karunamuni, PC Naha, KC Lau, A Al-Zaki, AV Popov, EJ Delikatny, ...
European radiology 26 (9), 3301-3309, 2016
Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics
N Bahrami, SJ Hartman, YH Chang, R Delfanti, NS White, R Karunamuni, ...
Journal of neuro-oncology 139 (3), 633-642, 2018
Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging
RA Karunamuni, KL Moore, TM Seibert, N Li, NS White, H Bartsch, ...
Radiotherapy and Oncology 118 (1), 29-34, 2016
4π plan optimization for cortical-sparing brain radiotherapy
VL Murzin, K Woods, V Moiseenko, R Karunamuni, KR Tringale, ...
Radiotherapy and Oncology 127 (1), 128-135, 2018
A genetic risk score to personalize prostate cancer screening, applied to population data
MP Huynh-Le, CC Fan, R Karunamuni, EI Walsh, EL Turner, JA Lane, ...
Cancer Epidemiology and Prevention Biomarkers 29 (9), 1731-1738, 2020
Search for novel contrast materials in dual-energy x-ray breast imaging using theoretical modeling of contrast-to-noise ratio
R Karunamuni, ADA Maidment
Physics in Medicine & Biology 59 (15), 4311, 2014
Identifying early diffusion imaging biomarkers of regional white matter injury as indicators of executive function decline following brain radiotherapy: A prospective clinical …
KR Tringale, T Nguyen, N Bahrami, DC Marshall, KM Leyden, ...
Radiotherapy and Oncology 132, 27-33, 2019
Exploring silver as a contrast agent for contrast-enhanced dual-energy X-ray breast imaging
R Karunamuni, A Tsourkas, ADA Maidment
The British journal of radiology 87 (1041), 20140081, 2014
Initial experience with dual-energy contrast-enhanced digital breast tomosynthesis in the characterization of breast cancer
S Gavenonis, K Lau, R Karunamuni, Y Zhang, B Ren, C Ruth, ...
International Workshop on Digital Mammography, 32-39, 2012
Altered network topology in patients with primary brain tumors after fractionated radiotherapy
N Bahrami, TM Seibert, R Karunamuni, H Bartsch, AP Krishnan, N Farid, ...
Brain connectivity 7 (5), 299-308, 2017
[18F] Fluoro-2-deoxy-2-d-glucose versus 3′-deoxy-3′-[18F] fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients
JC Wyss, R Carmona, RA Karunamuni, J Pritz, CK Hoh, LK Mell
Radiotherapy and Oncology 118 (1), 72-78, 2016
The system can't perform the operation now. Try again later.
Articles 1–20